Brighter signs logistics agreement with Speed Group.

08:00 / 19 December 2017 Brighter Press release

Brighter has launched a partnership with Speed Group for warehousing and inventory management of Actiste®, Brighter's unique service for diabetics that will be launched shortly. The partnership with Speed Group is part of the global logistics platform developed by Brighter and the company's development partner Sonat (,c2192884).

Brighter has chosen Speed Group as a long-term and proactive partner for managing the company's warehouse operations in Sweden.

"In order for us to succeed on the growth journey Brighter is now facing, we need flexible partners with a broad understanding of innovation and development. Speed Group meets our high standards regarding logistics management and we have a great deal of confidence in their organization," says Truls Sjöstedt, Brighter's CEO and founder.

"Speed Group's experience and ability to handle medical technology, as well as their organization's well-established quality system, was strongly contributing factors in our choice of partner," says Truls Sjöstedt. "The warehouse security classification was also highly valued in our evaluation."

Speed Group is one of the leading logistics experts in the region. Their business model offers flexibility and volume through complete solutions for warehouse, logistics, production, staff and recruitment services. Speed Group was founded in 2004 and since September 2015 the company's majority shareholder is Ratos.

"We are incredibly glad to be entrusted with the management of Brighter's logistics solution and that we were able to meet the company's high demands. It is a very interesting opportunity, and we look forward to developing this this long-term cooperation with Brighter," says Peter Nilsson, CEO at Speed Group.

For more information, please contact:

Henrik Norström, COO     
Telefon: +46 733 40 30 45     

Truls Sjöstedt, CEO     
Telefon: +46 709 73 46 00     

About Actiste
Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injection, and automatic logging and timing of all activity are done in a single unit. Actiste is connected via an autonomous and secure mobile connection, the information can be automatically shared with selected recipients through The Benefit Loop®, Brighter's open cloud-based service where data is collected, processed and analyzed.

Validated user-generated data, such as as test results, can be automatically transferred electronically to many different constituents. The patient selects when and how data is shared and who will have access to it. Through The Benefit Loop, different services can motivate patients with chronic illnesses to change their behavior, which can save lives, reduce relatives ' concerns, and release enormous healthcare resources.

About Brighter
"Driving Behavioral Change in Healthcare™"
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of the most serious healthcare problems: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and close associates, healthcare providers, research, pharmaceutical industry and society.

The Company's shares are listed on NASDAQOMX First North/BRIG ( Brighter's Certified Adviser on Nasdaq OMX First North is Remium Nordic AB +46 (0)8 - 454 32 50,,

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:00 CET on December 19, 2017.

Show as PDF

Show original from Cision


This information was distributed by Cision